Putting Science to Work

Genomics and Translational Biology

Genomics & Translational Biology

The Genomics & Translational Biology group provides services that cater to the continuum of drug discovery programs, as well as other applications that involve the characterization and quantification of DNA or RNA.

Genomics & Translational Biology

We are equipped with a 96 capillary DNA analyser (ABI) for Sanger sequencing and two platforms (Illumina™ MiSeq and Illumina™ NextSeq) for Next-Generation Sequencing (NGS).

NGS technology enables profiling of DNA and RNA at very high throughputs and high resolution to address a variety of biological questions. The technology can be exploited at early discovery stages (Lead identification, target-discovery, validation, mechanism of action); as well as during later stages (In vitro/in vivo studies, tumor biology, PDx models, biomarker discovery, genome editing, CDx development, patient stratification for trial design, drug repurposing).

The Syngene NGS facility offers a range of sequencing services that include the following:

  • Whole Genome Sequencing (De novo and resequencing)
  • Targeted Resequencing (custom amplicon panels)
  • Exome Sequencing
  • Transcriptome Sequencing
  • ChIP-Sequencing
  • Microbiome sampling by 16s rDNA sequencing
  • Whole Genome Shotgun Metagenomics

Our services include initial experimental design, sample processing (library preparation), sequencing, and tiered analysis based on requirements of the client.

This site is best viewed in Firefox (29+), Chrome (35+), or Microsoft Internet Explorer (9+)

Social Widget